Research and Markets: Progressive Supranuclear Palsy - Pipeline Review, H1 2013

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3cfzrf/progressive) has announced the addition of the "Progressive Supranuclear Palsy - Pipeline Review, H1 2013" report to their offering.

This report provides an overview of the indication's therapeutic pipeline. The analysis provides information on the therapeutic development for Progressive Supranuclear Palsy, complete with latest updates, and special features on late-stage and discontinued projects.

It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy. The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by a team of experts.

Scope

- A snapshot of the global therapeutic scenario for Progressive Supranuclear Palsy.

- A review of the Progressive Supranuclear Palsyproducts under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Progressive Supranuclear Palsypipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Progressive Supranuclear Palsy Overview

Therapeutics Development

An Overview of Pipeline Products for Progressive Supranuclear Palsy

Progressive Supranuclear Palsy Therapeutics under Development by Companies

Mid Clinical Stage Products

Comparative Analysis

Early Clinical Stage Products

Comparative Analysis

Discovery and Pre-Clinical Stage Products

Comparative Analysis

Progressive Supranuclear Palsy Therapeutics - Products under Development by Companies

Companies Involved in Progressive Supranuclear Palsy Therapeutics Development

Assessment by Monotherapy Products

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

Progressive Supranuclear Palsy Therapeutics - Drug Profile Updates

Progressive Supranuclear Palsy Therapeutics - Dormant Products

Progressive Supranuclear Palsy - Product Development Milestones

Featured News & Press Releases

Appendix

For more information visit http://www.researchandmarkets.com/research/3cfzrf/progressive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System